Reuters logo
BRIEF-Theraclion announces results of Echopulse study
February 12, 2015 / 7:27 AM / 3 years ago

BRIEF-Theraclion announces results of Echopulse study

Feb 12 (Reuters) - Theraclion SA :

* Announces study showing long-term effectiveness and safety of Echopulse in non-invasive treatment of breast fibroadenoma

* Ablation effectiveness proven by significant breast fibroadenoma volume reduction at 6 and 12-month follow-up

* Persistent decrease in fibroadenoma volume for all cases

* No ultrasound evidence of regrowth

* Symptoms reduction with pain and discomfort related to fibroadenoma completely resolved at end of follow-up Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below